Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Moore

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
Lancet (London, England)|May 25, 1974
Letter: Human calcitonin and serum-phosphateO L Silva, K L Becker, H P Selawry, et al.
Cancer Reports (Hoboken, N.J.)|June 22, 2026
Assessing Practice Patterns of Antidepressant Medication and Tamoxifen Use Among Patients With Hormone Receptor-Positive Breast CancerNerea Lopetegui-Lia, Alexandra Murray, Mariah Ondeck, et al.
Brain Research|August 4, 1980
Immunoreactive calcitonin in cerebrospinal fluid of manK L Becker, O L Silva, R M Post, et al.
Breast Cancer Research and Treatment|March 22, 2019
Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapyLeticia Varella, Akaolisa Samuel Eziokwu, Xuefei Jia, et al.
Cancer|August 1, 1979
Calcitonin as a marker for bronchogenic cancer: a prospective studyO L Silva, L E Broder, J L Doppman, et al.
Oncology and Therapy|November 20, 2021
Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the LiteratureMegan L Kruse, Irene M Kang, Nusayba A Bagegni, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 1, 1992
Serum procalcitonin as an index of inhalation injury in burnsE S Nylen, W O'Neill, M H Jordan, et al.
Clinical Breast Cancer|November 15, 2020
Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast CancerAkaolisa Samuel Eziokwu, Leticia Varella, Megan Lynn Kruse, et al.
The Breast Journal|February 3, 2021
Reducing time to treatment and patient costs with breast cancer: the impact of patient visitsSarah M C Sittenfeld, Zachary Greenberg, Zahraa Al-Hilli, et al.
Breast Cancer Research and Treatment|July 10, 2017
Predictive factors on outcomes in metaplastic breast cancerC Marc Leyrer, Camille A Berriochoa, Shree Agrawal, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
Lancet (London, England)|May 25, 1974
Letter: Human calcitonin and serum-phosphateO L Silva, K L Becker, H P Selawry, et al.
Cancer Reports (Hoboken, N.J.)|June 22, 2026
Assessing Practice Patterns of Antidepressant Medication and Tamoxifen Use Among Patients With Hormone Receptor-Positive Breast CancerNerea Lopetegui-Lia, Alexandra Murray, Mariah Ondeck, et al.
Brain Research|August 4, 1980
Immunoreactive calcitonin in cerebrospinal fluid of manK L Becker, O L Silva, R M Post, et al.
Breast Cancer Research and Treatment|March 22, 2019
Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapyLeticia Varella, Akaolisa Samuel Eziokwu, Xuefei Jia, et al.
Cancer|August 1, 1979
Calcitonin as a marker for bronchogenic cancer: a prospective studyO L Silva, L E Broder, J L Doppman, et al.
Oncology and Therapy|November 20, 2021
Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the LiteratureMegan L Kruse, Irene M Kang, Nusayba A Bagegni, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 1, 1992
Serum procalcitonin as an index of inhalation injury in burnsE S Nylen, W O'Neill, M H Jordan, et al.
Clinical Breast Cancer|November 15, 2020
Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast CancerAkaolisa Samuel Eziokwu, Leticia Varella, Megan Lynn Kruse, et al.
The Breast Journal|February 3, 2021
Reducing time to treatment and patient costs with breast cancer: the impact of patient visitsSarah M C Sittenfeld, Zachary Greenberg, Zahraa Al-Hilli, et al.
Breast Cancer Research and Treatment|July 10, 2017
Predictive factors on outcomes in metaplastic breast cancerC Marc Leyrer, Camille A Berriochoa, Shree Agrawal, et al.
Pageof 17